MASCC/AFSOS/ISOO 2024 Annual Meeting

We believe we have an important role to fill in society – bringing new, innovative treatments to patients with rare diseases.

Focus areas are within genetic & metabolic diseases, hematology & oncology and specialty care.

We operate products from phase 2 and all the way to mature products.

ESG is an integrated part of our business model.

Stay up to date with our latest news.

Telephone: +46 (0) 8 533 39 500
E-mail: [email protected]